Ezetimibe is a medicine used to help lower cholesterol levels in your blood. It works by stopping your body from absorbing too much cholesterol from the food you eat. This helps reduce the amount of bad cholesterol (LDL) and triglycerides in your blood, which can lower your risk of heart problems.
Every report comes from a Lived member, sent anonymously.
Have you tried Zetia (Ezetimibe) for High Cholesterol (Hypercholesterolemia)?
Ezetimibe, sold under the brand name Zetia and as a generic, is a prescription medicine that lowers LDL (low-density lipoprotein) cholesterol, the "bad" cholesterol that builds up in artery walls and raises the risk of heart attack and stroke. It is used alongside a cholesterol-conscious diet, most often together with a statin, the main family of cholesterol medicines (atorvastatin and rosuvastatin are examples). It can also be used on its own when someone cannot take a statin or other LDL-lowering treatment. Its approved uses include high cholesterol in adults, including the inherited form called familial hypercholesterolemia; the same inherited condition in children 10 and older, together with a statin; and, with fenofibrate (a medicine that mainly lowers triglycerides), a mixed pattern of high cholesterol and high triglycerides in adults. It is also approved for sitosterolemia, a rare inherited condition in which the body absorbs too much of the cholesterol-like sterols found in plant foods. Ezetimibe is also an ingredient in combination tablets, such as Vytorin (ezetimibe with the statin simvastatin). A combination tablet carries the other ingredient's own dosing rules and warnings, so it is not interchangeable with plain ezetimibe.
The cholesterol in the blood comes partly from what the liver makes and partly from cholesterol absorbed in the small intestine. Ezetimibe blocks a transporter in the lining of the small intestine that pulls cholesterol in. Less cholesterol reaches the liver, so the liver responds by pulling more LDL cholesterol out of the bloodstream. Statins work at a different step, by slowing the liver's own production of cholesterol. Because the two medicines act on different sources, their effects add together, which is why ezetimibe is so often paired with a statin. On its own, ezetimibe lowered LDL cholesterol by roughly 18% in clinical trials. Added to a statin a person was already taking, it lowered LDL by about a further quarter.
Ezetimibe is a 10 mg tablet taken by mouth once a day, with or without food. A missed dose can be taken as soon as it is remembered, but do not take two doses together to make up for one. People who also take a bile acid sequestrant, an older type of cholesterol powder or tablet such as cholestyramine, need to separate the doses: take ezetimibe at least 2 hours before or 4 hours after it, because the sequestrant lowers the amount of ezetimibe the body absorbs and can weaken its effect.
Most people notice no side effects. In trials of ezetimibe alone, the effects reported slightly more often than with a placebo were cold-like upper respiratory infections, diarrhea, joint pain, sinus infections, pain in the arms or legs and tiredness. Taken with a statin, muscle aches were among the effects reported slightly more often than with the statin alone. Rarely, ezetimibe can cause muscle damage, which can become severe (rhabdomyolysis). Most reported cases were in people also taking a statin or a fibrate. Unexplained muscle pain, tenderness or weakness should be reported to the prescriber promptly, especially with fever or a general feeling of being unwell. Rare reports also include inflammation of the liver, pancreas or gallbladder, so ongoing pain in the upper abdomen or yellowing of the skin or eyes is worth reporting. Allergic reactions such as rash and hives are uncommon. Swelling of the face, lips, tongue or throat, or trouble breathing, is a medical emergency: call 911.
Ezetimibe can raise liver enzymes, a blood-test sign of liver irritation; this was more common when it was started together with a statin than with a statin alone. A clinician may check liver tests when there is a reason to. Ezetimibe is not recommended for people with moderate or severe liver disease, because ezetimibe levels in the blood run higher and the effects of that are unknown. A few combinations change decisions. Cyclosporine, an immune-suppressing medicine used after organ transplants and for some autoimmune conditions, raises the levels of both drugs, so cyclosporine levels need monitoring. Ezetimibe is approved alongside fenofibrate, but the pair can increase the chance of gallstones; other fibrates, such as gemfibrozil, are not recommended with it. Because a statin is so often part of the plan, the statin's own interactions and warnings apply as well. There is too little information on ezetimibe in pregnancy or breastfeeding to judge the risk to a baby. Anyone who is pregnant, planning a pregnancy or breastfeeding should talk with the prescriber about whether to continue, keeping in mind that statins taken with it carry their own pregnancy guidance.
High cholesterol usually causes no symptoms, so ezetimibe will not make a person feel different. Its effect shows up on a blood test called a lipid panel. Most of the LDL drop appears within about two weeks, and a clinician may recheck LDL as early as four weeks after starting. In the US, LDL is reported in milligrams per deciliter (mg/dL); lower is better for the arteries, and the level worth aiming for depends on a person's overall heart risk, so it is worth asking what number the plan is working toward. The purpose of lowering LDL is to prevent heart attacks and strokes. The strongest evidence comes from a large trial in people recently hospitalized with a heart attack or unstable chest pain: adding ezetimibe to a statin lowered LDL further (to a typical level of about 54 mg/dL rather than 70) and, over about six years, modestly reduced heart attacks and strokes. It has not been shown to lower death rates, and there is less evidence for people without existing heart disease or for ezetimibe used without a statin. The effect is maintained with continued daily use, so for most people ezetimibe is a long-term treatment, with periodic lipid tests to confirm it is still doing its job. Stopping or changing it is a decision to make with the prescriber.
Last reviewed • Oct 2026
Educational content, not medical advice.
Do you find it to actually work in lowering cholesterol or is it just moving the numbers on the blood tests? I've heard statins are bad for you and you need cholesterol.